Rick Simpson Oil (RSO) in San Joaquin County: The Complete Guide by OilWell Cannabis

If you’re reading this from Stockton, Tracy, Lodi, Manteca, or anywhere across San Joaquin County’s sprawling agricultural heartland, you already know what it means to work hard and expect straight answers. You don’t have time for hype, and you definitely don’t have patience for snake oil. Neither do we. That’s why we built OilWell Cannabis the way we did — and it’s why we’re bringing this complete RSO education to San Joaquin County.

Rick Simpson Oil changed the global conversation about cannabis medicine. It started with one man’s desperation after a head injury in a Canadian hospital, traveled through a documentary that spread like wildfire across the internet, and eventually reached every corner of America — including the Central Valley. But here’s what most San Joaquin County residents don’t realize: the “RSO” label on products at local dispensaries often bears little resemblance to what Rick Simpson actually made. We’re here to change that, with formulas that honor the original spirit while solving the real safety and consistency problems that plagued traditional RSO.

Who Was Rick Simpson, and Why Does His Story Matter in San Joaquin County?

Rick Simpson wasn’t a doctor. He wasn’t a scientist. He was a power engineer from Nova Scotia — a blue-collar tradesman like so many agricultural mechanics, equipment operators, and processing plant workers across San Joaquin County. In 1997, while working at a hospital in Moncton, he fell from scaffolding and suffered a serious head injury. The conventional medical system failed him completely. Prescription medications either didn’t help or made his tinnitus, dizziness, and post-concussion symptoms worse. When he asked his doctor about cannabis, the door was slammed shut.

Sound familiar? We hear versions of this story every week from San Joaquin County residents — the farmworker who injured his back picking cherries in Lodi and got trapped in an opioid cycle, the veteran near Tracy dealing with PTSD who was handed benzos instead of real solutions, the cancer patient in Stockton told there are no more options. Rick Simpson’s frustration with institutional medicine resonates deeply here, where many communities have historically lacked access to comprehensive healthcare.

Simpson discovered the 1974 NIH-funded study from Virginia that showed THC could slow tumor growth in mice. That study — intended to prove cannabis caused harm — became his catalyst. Then in 2003, three bumps on his arm were diagnosed as basal cell carcinoma. Against medical advice, he applied concentrated cannabis oil and claimed the lesions disappeared in four days. No biopsy confirmation exists. No independent medical verification was published. But this personal testimony launched a global movement.

Important context: Simpson’s account is personal testimony, not medical evidence. It cannot be evaluated as clinical proof. But it is historically significant as the catalyst that made “RSO” the most recognized term for full-spectrum cannabis extract worldwide.

The Traditional RSO Protocol: What San Joaquin County Needs to Know

After his 2003 experience, Simpson committed himself to producing oil and giving it away for free. His protocol was specific: 60 grams of oil over approximately 90 days. For San Joaquin County residents researching “RSO dosing protocol,” here’s the exact schedule Simpson documented:

Week 1: Start with a dose the size of half a grain of rice — about 10-15mg — three times daily. Total daily intake: 30-45mg.

Weeks 2-5: Double the dose every four days. By week five, reach approximately 1 gram (1,000mg) per day, divided into three doses.

Weeks 5-12: Maintain 1 gram daily until all 60 grams are consumed.

Administration: Primary method was oral (sublingual or swallowed). Topical application for skin lesions. Inhalation was acknowledged for immediate symptom relief but not as primary treatment.

Tolerance: Simpson claimed patients develop tolerance to psychoactive effects within 3-4 weeks. He recommended nighttime dosing initially and warned against driving.

Post-protocol: Maintenance dosing of 1-2 grams monthly, indefinitely.

Dietary advice: Reduce sugar, avoid processed foods — general wellness recommendations, not systematic protocols.

Critical Context for San Joaquin County Evaluating This Protocol

This protocol was designed by one person based on personal experience. It was never developed through clinical trials, dose-finding studies, or formal research. Several realities matter for San Joaquin County residents considering this approach:

• No controlled trial validation. There are zero published randomized controlled trials evaluating this specific 60-gram/90-day protocol for any cancer type or condition.
• Crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content varied wildly.
• Extreme THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming 60-90% THC content, that’s 600-900mg of delta-9 THC per day — far exceeding anything studied clinically. For perspective, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20mg daily.
• Real risks at these doses. Consuming 600-900mg of THC daily carries serious risks: severe intoxication, anxiety, panic, tachycardia, hypotension, cannabis use disorder, and potential psychiatric effects [1][13][14][15].
• Oncology complexity. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as a primary treatment — potentially instead of proven therapies — introduces harm beyond the oil itself.

For San Joaquin County cancer patients at facilities like St. Joseph’s Medical Center in Stockton or Memorial Hospital in Modesto, this context is crucial. RSO education should complement medical care, not replace it.

What Traditional RSO Actually Was: The Product Truth

Many San Joaquin County residents see “RSO” on dispensary shelves and assume it’s a standardized medicine. It never was. Here’s what Rick Simpson actually produced:

Source material: Single high-THC indica strain, no standardization. Every batch different based on whatever plant was available.

Extraction solvent: Naphtha (petroleum-based lighter fluid) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other carcinogens.

Process: Bucket, solvent, agitation, filter, rice cooker evaporation. The heat converted all THCa to THC and destroyed virtually all terpenes.

Appearance: Nearly black, thick, tar-like oil with possible solvent-residual smell.

Cannabinoid profile: 60-90% delta-9 THC (estimated, never lab-verified). Minor cannabinoids present at whatever ratios the source plant contained — uncontrolled, unmeasured.

Terpene content: Minimal to none. The solvent plus heat process stripped them completely.

Standardization: None. Every batch differed. No Certificates of Analysis, no contaminant screening.

Residual solvent risk: Incomplete purging leaves potentially harmful residues. Difficult to verify without lab testing.

For San Joaquin County’s agricultural workers who understand crop processing and chemical safety, these production methods should raise immediate red flags. This is not how safe consumables are made.

The Legacy and Evolution: Why Modern RSO Is Different

The term “RSO” has become generic. Many products bearing the name today share little with Simpson’s original. Simpson himself was critical of commercial products, believing they betrayed his free-access model. Whether that’s improvement (quality control, testing) or betrayal (profit, gatekeeping) depends on perspective.

What isn’t disputed is that modern RSO has evolved dramatically. The oil we produce at OilWell Cannabis is informed by Rick Simpson’s vision but deliberately different in ways that solve the real problems his method created.

Traditional RSO vs. OilWell Formulated RSO: The Comparison That Matters

Why OilWell’s Formulas Diverge: Five Evidence-Motivated Choices

Our formulas aren’t different for marketing — they’re different because the science and safety data demand it:

1. Multi-cannabinoid approach. Traditional RSO used whatever single strain was available. Our formula includes seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from diversity, even while robust clinical proof of whole-formula synergy remains limited [20][29].

2. Terpene preservation and addition. Traditional RSO had essentially no terpenes. We include live terpenes at 5% with a specific seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — because terpene bioactivity is plausible and supported at the preclinical level, even if human confirmation for cannabis-specific effects remains developing [20][21][23][24][25][26][27][28][29].

3. THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500mg as a distinct ingredient, preserving the acidic precursor because THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost during conversion to THC [12].

4. Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. Our formula uses only 90mg of delta-9 THC total while distributing 16,590mg across other cannabinoids. This reflects the broader research landscape rather than single-compound dominance.

5. Product format innovation. Simpson envisioned only oral oil. We offer both a 30mL sublingual oil and a 1-gram vape cartridge, acknowledging that different delivery routes have different pharmacokinetic profiles [14].

The Decarboxylation Choice: Patient-Controlled Potency for San Joaquin County

This is where our formula fundamentally changes what RSO can be. Traditional RSO was always psychoactive. Our sublingual oil gives San Joaquin County residents three distinct usage options from one product:

Option 1 — Raw, no heat. All 1,500mg stays as THCa — completely non-psychoactive. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is perfect for daytime functional use in San Joaquin County — whether you’re operating farm equipment in Lodi, working a shift in Stockton’s distribution centers, or commuting on I-5. Zero impairment. Zero risk of failing a workplace drug test from delta-9 THC.

Option 2 — Fully activated, home decarboxylation. Heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container converts 1,500mg THCa into approximately 1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, this yields ~1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because decarboxylation occurs after purchase at your discretion.

Option 3 — Vape, auto-decarboxylation. Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Every inhalation delivers freshly decarboxylated cannabinoids with 1-2 minute onset — the fastest RSO delivery available.

The conversion chemistry: 1mg THCa = 0.877mg delta-9 THC after decarboxylation, reflecting loss of a CO₂ molecule.

This design puts potency control entirely in your hands — aligning with Rick Simpson’s principle that patients should control their medicine, but implementing it through actual chemistry rather than one-size-fits-all dosing.

OilWell Cannabis: Our Story, From Bentley to San Joaquin County

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But our origins trace back to McAllen, Texas — right across the river from Reynosa, Mexico, in one of the most economically challenged and dangerous border regions. Colin’s childhood involved transporting items across the border, watching best friends killed or imprisoned, and leaving home at sixteen to escape the violence. He faced every form of violence imaginable, both in the streets and across the border.

Despite these dangers, Colin chose cannabis over darker paths. He grew up in the traditional cannabis world pre-legalization, learning the plant intimately. Later, he became a formally trained software engineer, doing custom development for Baylor College of Medicine — combining deep plant knowledge with medical-grade technical precision.

Bentley: The Dog Who Started Everything

Our company’s origin story begins with a dog named Bentley. Bentley was more than a pet — he was family. When veterinarians delivered the euthanasia verdict for his paralysis and organ-destroying pain medications, Colin refused to accept it. A rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin created CBD golden paste — a specialized cannabinoid formula for pets. Bentley got up. He walked over and brought his ball to play. From paralyzed and facing death to fetching his ball. Dogs don’t respond to placebo. This was cannabinoid medicine succeeding where pharmaceuticals failed.

Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered — Bentley’s life depended on formula accuracy, not guesswork.

Colin’s Personal Battle: PTSD and Benzo Addiction

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he quit Xanax cold turkey — a notoriously difficult and dangerous feat — he used the cannabinoid knowledge developed keeping Bentley alive.

Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. He personally uses the vape form for insomnia and severe PTSD. This isn’t theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Our Open-Source Philosophy: Free Formulas for San Joaquin County

OilWell publishes our complete RSO formulas publicly — every cannabinoid, every milligram, every percentage. If you can’t afford our products, you can source the ingredients and make your own. This is a direct echo of Rick Simpson’s free-distribution ethos, adapted for the modern cannabinoid marketplace.

The original open-source formula we published — the CBD golden paste that saved Bentley:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1-2 teaspoons freshly ground black pepper (critical for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions:

1. Mix turmeric and water in saucepan over low heat, stirring continuously until thick paste forms (7-10 minutes)
2. Add coconut oil and pepper, stir thoroughly
3. Cool, store in refrigerator up to two weeks
4. Mix with pet’s food once or twice daily

This pattern — publish the formula that saved Bentley before we ever sold RSO — demonstrates our open-source ethos isn’t marketing. It’s foundational behavior.

Deep Science for San Joaquin County: Understanding Every Compound

San Joaquin County residents deserve more than marketing claims. You deserve to know what the research actually says. Here’s our evidence-based breakdown:

Cannabinoids: What the Science Shows

CBD (4,500mg in our sublingual formula): Strongest human evidence in our formula. Best supported for rare epilepsies (FDA-approved Epidiolex). 2024 systematic review of 316 participants found significant anxiolytic signal but authors stress limited clinical sample [3]. Pain literature is promising but heterogeneous [4]. Sleep research remains methodologically weak [5]. 2023 review found real signal for liver enzyme elevation in some contexts, especially important for concentrated oral products [6]. NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver abnormalities, and drug interactions [1].

CBG (3,000mg): Mostly review-level and preclinical; human evidence sparse [7][8]. Pharmacology distinct from THC/CBD, interacting with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling [7]. Reviews discuss neurologic disorders, inflammatory bowel disease, antibacterial activity — but these are pharmacology-led hypotheses, not mature human conclusions [7][8]. Commercially sold despite thin evidence base [7].

Delta-8 THC (6,000mg): Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 [9]-[11]. 2022 review: delta-8 and delta-9 have broadly similar pharmacokinetic/pharmacodynamic behavior; delta-8 is partial CB1 agonist with cannabimimetic activity, less potent than delta-9, likely due to weaker CB1 affinity [9]. 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, and public-health concerns rather than strong human trials; noted reports of adverse consequences [10]. Chemistry review reinforces commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels [11].

THCa (1,500mg): Important chemically and formulation-wise, but low on direct human therapeutic evidence [12]. Acidic precursor of THC, may represent large share of THC-related content in raw plant. Key issue: decarboxylates to THC during heating and can change during storage/processing [12]. Does not produce psychoactive effects associated with THC — but only if molecule stays acidic and isn’t substantially decarboxylated [12]. In vitro and rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities — not equivalent to established human outcomes [12].

Delta-9 THC (90mg): Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15]. NCCIH identifies relevance to chemo-related nausea/vomiting, appetite/weight loss in HIV/AIDS, some MS- and pain-related outcomes [1]. 2022 systematic review of cannabis-based products for chronic pain found high-THC products may provide short-term benefit but increased dizziness, sedation, nausea, treatment discontinuation [13]. Classic pharmacokinetics: inhaled THC produces effects within seconds-minutes, peaks 15-30 minutes, tapers over hours; oral THC has later onset, later peak, longer duration [14]. 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, concerning signals for anxiety/depression in nontherapeutic settings [15]. Safety concerns include anxiety/panic at high doses, tachycardia, blood-pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].

CBN (750mg): Weak human evidence; marketing moved ahead of data [12][16][17]. Often marketed for sleep/sedation, but clinical support far thinner than market suggests [16][17]. 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims [16]. 2024 updated cannabis sleep review concluded research still doesn’t match real-world use scale, need for better-designed, adequately powered trials remains substantial [17]. THC can degrade toward CBN under certain conditions, explaining why CBN often discussed in aging/oxidized cannabis contexts [12].

CBC (750mg): Emerging, intriguing, overwhelmingly preclinical/review-based [18][19]. 2024 focused review argues distinct pharmacodynamics, pharmacokinetics, receptor behavior relative to better-known cannabinoids; highlights antinociceptive, antibacterial, anti-seizure as especially interesting research targets [18]. Older literature summarizing animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance — not yet strong evidence for patient-facing claims [19]. 2024 CBC review explicitly notes over-the-counter CBC products already sold despite little evidence establishing clinical efficacy or safety [18].

Terpenes: The Aromatic Dimension

Terpenes need stricter interpretation than cannabinoids. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. 2024 entourage-effect review makes this especially important: terpene bioactivity is plausible and sometimes compelling, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene (citrus-bright): Largely review/preclinical, with useful safety literature [20]-[22]. 2021 review describes multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities — overwhelming share from nonhuman/non-cannabis literature [21]. Safety note: limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing literature [22].

Myrcene: Mostly preclinical, very limited human evidence [20][23]. 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties, discusses possible mechanisms, explicitly states human studies lacking [23]. Often invoked as proven sedating terpene explaining couch-lock — stronger claim than human evidence supports [20][23].

Caryophyllene (pepper/spice): Among most mechanistically interesting because of direct cannabinoid-system relevance, but still mostly preclinical [24]. 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist — unusual, especially relevant for pharmacologic rather than purely aromatic discussion [24]. Research themes: anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective — but human clinical confirmation remains limited [24].

Pinene (forest-fresh): Promising preclinical literature, weak human clinical confirmation [20][25]. 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized well-designed clinical trials lacking [25]. Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].

Linalool (floral, lavender): Similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while still emphasizing lack of robust human trials [25]. Separate review literature discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26]. Safety note: oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22].

Humulene (earthy, woody): Translationally interesting, but early [20][27]. 2024 scoping review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27]. Findings valuable for hypothesis generation, but don’t yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

Terpinolene (piney, fruity, sparkling): Among least clinically characterized terpenes in this file [20][28]. 2021 terpinolene review screened 2,449 records, included 57 studies, concluded range of reported biological effects but evidence base still dominated by in silico, in vitro, animal studies rather than human trials [28].

Our RSO Formulas: Complete Transparency for San Joaquin County

We’re publishing our exact formulas because you deserve to know what you’re putting in your body — and because if you can’t afford our products, you should be able to make your own. This is the complete specification.

RSO Sublingual Oil — $129.99

Cannabinoid Content (30mL bottle, 553mg/mL):

• CBD: 4,500mg
• CBG: 3,000mg
• Delta-8 THC: 6,000mg
• THCa: 1,500mg
• Delta-9 THC: 90mg
• CBN: 750mg
• CBC: 750mg
• Total: 16,590mg cannabinoids

Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)

Base: Organic MCT oil

Dosing: Graduated dropper in 0.1mL increments

Pharmacokinetics:

• Onset: 15-45 minutes (sublingual absorption)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Approximately 40-60 doses per bottle depending on serving size

RSO Vape Cartridge — $49.99

Cannabinoid Content (1g cartridge):

• CBD: 30%
• CBG: 20%
• Delta-8 THC: 15%
• THCa: 10%
• CBN: 10%
• CBC: 10%
• Total: 900mg+ cannabinoids

Live Terpenes: 5%+

Compatibility: 510-thread universal battery

Pharmacokinetics:

• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable by inhalation technique)
• Automatic THCa decarboxylation at vaping temperature (400-450°F)

Terpene Profile: Sensory Experience

Both products share the same seven-terpene profile:

• Limonene: Citrus-bright aroma, multifunctional monoterpene with antioxidant/anti-inflammatory potential [21]
• Myrcene: Earthy notes, anxiolytic and analgesic properties in preclinical models [23]
• Caryophyllene: Pepper/spice aroma, selective CB2 receptor agonist [24]
• Pinene: Forest-fresh scent, neuroprotective signals in preclinical studies [25]
• Linalool: Floral lavender notes, stress/mood pharmacology interest [26]
• Humulene: Woody/earthy aroma, anti-inflammatory preclinical evidence [27]
• Terpinolene: Piney/fruity sparkling character, broad biological effects [28]

When to Use Each Format: Practical Guidance for San Joaquin County

How Our RSO Compares: Factual Analysis

We don’t hide from comparison. Here’s how our formula stacks up:

OilWell RSO vs. Typical Dispensary RSO (California)

OilWell RSO vs. Typical Hemp CBD RSO

Condition-Specific Usage Context for San Joaquin County

Important Disclaimer: These contexts are informed by cannabinoid research cited above and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT substitutes for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: delta-8 antiemetic [9], delta-9 nausea/vomiting [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0mL decarbed sublingual — pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain [4], delta-9 pain [13], caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN — dosage level investigated in 2024 sleep literature [16][17]
• At 1.0mL: Delivers 25mg CBN — above 20mg threshold associated with reduced sleep disturbance [16][17]

Anxiety and Stress

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0mL sublingual — full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General Titration Principle

Start low, go slow. Begin with 0.25-0.5mL sublingual. Assess effects over 2-3 hours before increasing. Individual responses vary by body weight, metabolism, tolerance, medications, and other factors.

Delivery to San Joaquin County: How You Get Our Products

We operate the only same-day RSO delivery system in Houston, but for San Joaquin County residents, we offer comprehensive shipping options:

Standard Shipping to San Joaquin County

• Carrier: USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 business days)
• Packaging: Discreet, no cannabis branding visible
• Tracking: Provided for all orders
• Temperature control: Stable packaging for Central Valley summer heat
• Signature option: Available for security

San Joaquin County Shipping Rates

• Flat rate for California addresses: $9.99
• Free shipping on orders over $150
• International shipping available to countries where hemp products are legal (customer accepts customs responsibility)

Legal Framework for San Joaquin County
California legalized recreational cannabis in 2016. However, our RSO products are Farm Bill compliant — containing less than 0.3% delta-9 THC — making them legal to ship nationwide, including to San Joaquin County. California residents can legally purchase hemp-derived products regardless of medical card status. Age requirement: 21+ for RSO products.

Media Recognition: Third-Party Validation

Between 2019 and 2023, ABC13 Houston — the ABC affiliate serving America’s fourth-largest city — featured OilWell Cannabis in seven distinct news segments. Five different reporters sought us out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff. No other Houston cannabis operator appears with that frequency or breadth.

September 15, 2019: CBD Business Boom
Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” This philosophy drives everything we do.

March 22, 2021: Decriminalization
Colin’s therapy quote: “Pain comes in a lot of different forms.” This went deeper than prior interviews, positioning us at the intersection of Texas innovation and federal momentum.

May 24, 2021: Delta-8 Investigation
Steve Campion’s iconic exchange: “Why would someone want to smoke that?” Colin: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* Radical honesty on mainstream TV with medical expert Dr. Michael Weaver balancing caution and Heather Fazio advocating for regulation over prohibition.

August 20, 2021: COVID Vaccine Giveaway
We donated approximately $35,000 in product (1,000 caviar pre-rolls) to encourage vaccination, coordinated with city of Houston, with zero political agenda.

October 19, 2021: Delta-8 Ban
When Texas classified Delta-8 as Schedule I overnight, we proactively removed all products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics. We absorbed major revenue loss to act ethically.

October 7, 2022: Biden Pardon Feature
Colin revealed personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything.” and “I would love to see people not get hurt for this anymore.” This transforms the entire media record — every quote carries weight from someone who lived the consequences.

April 21, 2023: 4/20 Renaissance
Colin’s framing: “Right now is actually a pretty – like Renaissance – pretty important time that should be enjoyed now.” Positioning OilWell at the frontier of legal cannabis evolution.

These features are not marketing materials. They are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as the most credible, quotable, accessible voice in Houston’s legal cannabis industry. That recognition cannot be purchased — it can only be earned.

How OilWell Formulas Connect to Evidence

Every cannabinoid in our formula has its evidence profile detailed above. Every terpene is covered with preclinical and review-level literature. We anchor our product claims to per-compound evidence summaries that explain what is well-supported, what is emerging, and what is overstated.

When our RSO Guide Page makes specific research claims, this document provides the source evaluation context — the same peer-reviewed citations, evidence-tier assessments, and cautious interpretation framework.

We don’t exempt ourselves from the evidence standards applied to the broader field. That is intentional. As Colin said in 2019: people deserve the best possible information so they can give it a fair shot and decide for themselves whether it’s right or wrong for them.

Common Overstatements We Avoid

We refuse to contribute to the misinformation plaguing the cannabis industry. Here are claims we won’t make, and the more accurate statements:

Overstatement: CBN is a clinically proven sleep cannabinoid.
Accurate: Specific sleep evidence for CBN remains weak, with no strong validated-trial base [16][17].

Overstatement: Myrcene is a proven human sedative.
Accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for sedation claims is limited [20][23].

Overstatement: Terpenes have proven entourage effects.
Accurate: Entourage hypotheses are worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

Overstatement: THCa is always non-psychoactive.
Accurate: THCa itself isn’t THC, but heating converts it, changing effective exposure [12].

Overstatement: Delta-8 is safe because it’s hemp-derived.
Accurate: Delta-8 is psychoactive, pharmacologically close to delta-9, with less robust safety characterization [9]-[11].

The Practical Bottom Line for San Joaquin County

Our RSO formulas contain:

Most evidence-developed actives: CBD and delta-9 THC, but even here, strong evidence is concentrated in specific indications (seizures, chemo nausea) rather than broad wellness claims.

Not trivial: Delta-8 THC — real pharmacologic activity, incomplete human safety characterization.

Chemically dynamic: THCa changes with processing — raw vs. decarbed produce完全不同的 experiences.

Clinically immature: CBG, CBN, CBC — scientifically credible but early-stage, requiring careful claim framing.

Careful terpene claims: Aroma, flavor, plausible bioactivity — but compound-specific human therapeutic claims should stay conservative.

Legal Compliance and Disclaimers

Age requirement: 21+ for all RSO products.

FDA disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.

Safety warnings: May cause drowsiness or impairment. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids. Consult a physician before use if pregnant, nursing, or have any medical condition. Keep out of reach of children.

THCa conversion notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws. OilWell ships with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal risk.

Buyer responsibility: You are responsible for checking San Joaquin County and California laws regarding cannabinoid products. Void where prohibited by law.

Why San Joaquin County Chooses OilWell

From the agricultural fields of Lodi to the industrial corridors of Stockton, from the suburban neighborhoods of Tracy to the historic streets of Manteca, San Joaquin County residents share common values: honesty, hard work, and no tolerance for bullshit. That’s our language too.

We don’t promise miracles. We promise transparency:

• Complete formula publication so you know exactly what you’re getting
• Third-party lab testing for every batch
• Patient-controlled potency — you decide psychoactive or non-psychoactive
• Nationwide shipping to San Joaquin County with discreet packaging
• Evidence-based education that respects your intelligence
• Founder with personal conviction history who understands the stakes
• Seven ABC13 features documenting our credibility over four years

Ready to Try RSO in San Joaquin County?

Order online: OilWellCBD.com

Questions? Call (832) 416-2816 or email [email protected]

Follow us: Instagram @oilwellcbd

Visit our Houston dispensary: 810 Richmond Avenue, Houston, TX 77006 (if you’re ever in Texas)

For San Joaquin County residents seeking alternatives to pharmaceuticals, supporting a loved one through cancer treatment, managing chronic pain from agricultural work, or finding relief from PTSD — we offer the most transparent, evidence-informed RSO formulas available. No hype. No snake oil. Just the best possible version so you can give it a fair shot and decide if it’s right for you.

Because whether you’re in Stockton, Tracy, Lodi, Manteca, or anywhere across San Joaquin County’s 1,400 square miles, you deserve access to cannabis medicine that honors both science and humanity. That’s what we built. That’s what we ship to your door. That’s OilWell Cannabis.